SHARPE·IQStart free
Menu
TodayResearchEarningsToolsPricingSign in
MEDS reported Third quarter 2026 results. The price and volatility reaction is pending.
MEDSearnings

Earnings reactions, page 2

DataMEDS AI, Inc. (MEDS) Q3 FY2026 earnings

November 14, 2026 · SharpeIQ Research Desk

Reported results

  • Third quarter 2026 revenue was $2.668980 million.
  • Net income was $10.535560 million for the quarter ended September 30, 2026.
  • Net income attributable to DataMeds AI was $10.589764 million for the third quarter of 2026.
  • Diluted net income per common share was $2.72 for the third quarter of 2026.
  • Loss from operations was $3.373956 million for the third quarter of 2026.

Notes

The Company regained full compliance with Nasdaq listing standards on October 19, 2026.

Price and volatility reaction

Source

The figures above come from the earnings release the company filed with the SEC on 2026-11-13 (8-K, Item 2.02). Read the original filing on sec.gov.

See this live in SharpeIQ

IV rank, historical IV and the single-ticker tools. The scanner and AI research are paid plans.

Open IV Rank →